To provide maximum value to their internal clients, pharmaceutical and biotech companies must continue to innovate. In order to enhance business impact and reduce redundancy, savvy Market Research leaders must determine the right mix of internal staff, external personnel, and automated reporting.
In the changing pharmaceutical landscape, Market Research groups are faced with the challenge of regularly generating a significant number of secondary reports while also continuing to provide more strategic insights. Burdened with headcount constraints and new products to support, executives can potentially gain critical efficiencies through the shrewd use of outsourced personnel and system automation.
To identify strategies, solutions, and the transition process Market Research groups are undergoing in the near future, Best Practices, LLC, a world leader in biopharmaceutical benchmarking and best practice research, performed this research to help pharma and biotech executives and managers create more efficient groups and processes.